跳至主要内容
临床试验/CTRI/2024/02/063348
CTRI/2024/02/063348尚未招募Unknown

Genetic polymorphism and treatment outcomes in opioid use disorder patients: A study of OPRD1 and OPRM1 variants in Buprenorphine and Naloxone pharmacotherapy - NI

PGIMER, Chandigarh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age: 18-65 years, Either gender, Diagnosis of moderate or severe OUD as per DSM-V criteria or opioid dependence as per ICD-11, Providing written informed consent, Participants within a week of initiating buprenorphine naloxone (BNX) treatment.

排除标准

  • Presence of cardiomyopathy, Patients with liver disease

研究者

相似试验